Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells

References

• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan 23;136(2):215–233.
   PubMed Web of Science ®Google Scholar
• Ha TY. MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw. 2011 Jun;11(3):135–154.
   PubMedGoogle Scholar
• Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014 Aug 18;24(16):R762–76.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006 Apr;6(4):259–269.
   PubMed Web of Science ®Google Scholar
• Chan E, Prado DE, Weidhaas JB. Cancer microRNAs: from subtype profiling to predictors of response to therapy. Trends Mol Med. 2011 May;17(5):235–243.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007 Nov;13(11):460–469.
   PubMed Web of Science ®Google Scholar
• Labbaye C, Testa U. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol. 2012;5:13.
   PubMed Web of Science ®Google Scholar
• Iacona JR, Lutz CS. miR-146a-5p: Expression, regulation, and functions in cancer. Wiley Interdiscip Rev: RNA 2019 Jul;10(4):e1533.
   PubMed Web of Science ®Google Scholar
• Cornett AL, Lutz CS. Regulation of COX-2 expression by miR-146a in lung cancer cells. RNA. 2014 Sep;20(9):1419–1430.
   PubMed Web of Science ®Google Scholar
• Iacona JR, Monteleone NJ, Lutz CS. miR-146a suppresses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells. Oncotarget. 2018 Jun 1;9(42):26751–26769.
   PubMedGoogle Scholar
• Chen G, Umelo IA, Lv S, et al. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PloS One. 2013;8(3):e60317.
   PubMed Web of Science ®Google Scholar
• Li YL, Wang J, Zhang CY, et al. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2. Oncotarget. 2016 Sep 13;7(37):59287–59298.
   Google Scholar
• Martinez NJ, Walhout AJ. The interplay between transcription factors and microRNAs in genome-scale regulatory networks. Bioessays. 2009 Apr;31(4):435–445.
   PubMed Web of Science ®Google Scholar
• Reimand J, Arak T, Adler P, et al. g:Profiler-a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 2016 Jul 8;44(W1):W83–9.
   PubMed Web of Science ®Google Scholar
• Behrens C, Feng L, Kadara H, et al. Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions. Clin Cancer Res off J Am Assoc Cancer Res. 2010 Jan 1;16(1):34–44.
   PubMed Web of Science ®Google Scholar
• Starczynowski DT, Lockwood WW, Delehouzee S, et al. TRAF6 is an amplified oncogene bridging the RAS and NF-kappaB pathways in human lung cancer. J Clin Invest. 2011 Oct;121(10):4095–4105.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang L, Zhao J, et al. TGF-beta-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer. Lung Cancer. 2015 Mar;87(3):249–257.
   PubMed Web of Science ®Google Scholar
• Cheung KS, Sposito N, Stumpf PS, et al. MicroRNA-146a regulates human foetal femur derived skeletal stem cell differentiation by down-regulating SMAD2 and SMAD3. PloS One. 2014;9(6):e98063.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li Y, Wang H, et al. miR-146a-5p acts as a negative regulator of TGF-beta signaling in skeletal muscle after acute contusion. Acta Biochim Biophys Sin (Shanghai). 2017 Jul 1;49(7):628–634.
   PubMed Web of Science ®Google Scholar
• Karthikeyan A, Gupta N, Tang C, et al. Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment. Oncotarget. 2018 May 18;9(38):24950–24969.
   PubMedGoogle Scholar
• Pu W, Shang Y, Shao Q, et al. miR-146a promotes cell migration and invasion in melanoma by directly targeting SMAD4. Oncol Lett. 2018 May;15(5):7111–7117.
   PubMed Web of Science ®Google Scholar
• Kim DH, Chang MS, Yoon CJ, et al. Epstein-Barr virus BARF1-induced NFkappaB/miR-146a/SMAD4 alterations in stomach cancer cells. Oncotarget. 2016 Dec 13;7(50):82213–82227.
   PubMedGoogle Scholar
• Xiao B, Zhu ED, Li N, et al. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep. 2012 Feb;27(2):559–566.
   PubMed Web of Science ®Google Scholar
• Lutz CS, Cornett AL. Regulation of genes in the arachidonic acid metabolic pathway by RNA processing and RNA-mediated mechanisms. Wiley Interdiscip Rev: RNA 2013 Sep-Oct;4(5):593–605.
   PubMed Web of Science ®Google Scholar
• Sampey AV, Monrad S, Crofford LJ. Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2. Arthritis Res Ther. 2005;7(3):114–117.
   PubMed Web of Science ®Google Scholar
• Zhou YX, Zhao W, Mao LW, et al. Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a. Int J Biochem Cell Biol. 2018;104:25–33.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang W, Zhang L, et al. miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2. Br J Cancer. 2016 Dec 6;115(12):1548–1554.
   PubMed Web of Science ®Google Scholar
• Mei J, Bachoo R, Zhang CL. MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol. 2011 Sep;31(17):3584–3592.
   PubMed Web of Science ®Google Scholar
• Comer BS, Camoretti-Mercado B, Kogut PC, et al. MicroRNA-146a and microRNA-146b expression and anti-inflammatory function in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2014 Nov 1;307(9):L727–34.
   PubMed Web of Science ®Google Scholar
• Nguyen MA, Karunakaran D, Geoffrion M, et al. Extracellular vesicles secreted by atherogenic macrophages transfer microRNA to inhibit cell migration. Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):49–63.
   PubMed Web of Science ®Google Scholar
• Cheng HS, Sivachandran N, Lau A, et al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med. 2013 Jul;5(7):949–966.
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev: RNA 2010 Sep-Oct;1(2):214–229.
   PubMed Web of Science ®Google Scholar
• Srikantan S, Gorospe M. HuR function in disease. Front Biosci. 2012;17:189–205.
   PubMed Web of Science ®Google Scholar
• Gyorffy B, Surowiak P, Budczies J, et al. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PloS One. 2013;8(12):e82241.
   PubMed Web of Science ®Google Scholar
• Kudo-Saito C, Shirako H, Ohike M, et al. CCL2 is critical for immunosuppression to promote cancer metastasis. Clin Exp Metastasis. 2013 Apr;30(4):393–405.
   PubMed Web of Science ®Google Scholar
• Arenberg DA, Keane MP, DiGiovine B, et al. Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother. 2000 May;49(2):63–70.
   PubMed Web of Science ®Google Scholar
• Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000 Jul 1;96(1):34–40.
   PubMed Web of Science ®Google Scholar
• Li X, Tai HH. Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein −1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells. PloS One. 2013;8(1):e54073.
   PubMed Web of Science ®Google Scholar
• Fan J, Ishmael FT, Fang X, et al. Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Iimmunol. 2011 Feb 15;186(4):2482–2494.
   PubMed Web of Science ®Google Scholar
• Broderick JA, Zamore PD. MicroRNA therapeutics. Gene Ther. 2011 Dec;18(12):1104–1110.
   PubMed Web of Science ®Google Scholar
• Chakraborty C, Sharma AR, Sharma G, et al. Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine. Mol Ther Nucleic Acids. 2017 Sep;15(8):132–143.
   Google Scholar
• Christopher AF, Kaur RP, Kaur G, et al. MicroRNA therapeutics: Discovering novel targets and developing specific therapy. Perspect Clin Res. 2016 Apr-Jun;7(2):68–74.
   PubMedGoogle Scholar
• Rusca N, Monticelli S. MiR-146a in Immunity and Disease. Mol Biol Int. 2011;2011:437301.
   PubMedGoogle Scholar
• Kim JI, Lakshmikanthan V, Frilot N, et al. Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome. Mol Cancer Res. 2010 Apr;8(4):569–577.
   PubMed Web of Science ®Google Scholar
• Chandramouli A, Onyeagucha BC, Mercado-Pimentel ME, et al. MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers. Cancer Biol Ther. 2012 Feb 1;13(3):175–183.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang B, Bi J, et al. Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer. Med Oncol. 2011 Dec;28;(Suppl 1):S577–85.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao W, Guo Y, et al. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis. Oncology. 2009;76(6):420–429.
   PubMed Web of Science ®Google Scholar
• Wei L, Jin Z, Yang S, et al. TCGA-assembler 2: software pipeline for retrieval and processing of TCGA/CPTAC data. Bioinformatics. 2018 May 1;34(9):1615–1617.
   PubMed Web of Science ®Google Scholar